Antiviral Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 70 pages | ID: A765CB0496C8EN
Market Monitor Global

Abstracts

Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.

This report contains market size and forecasts of Antiviral Drugs in global, including the following market information:

Global Antiviral Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Antiviral Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Antiviral Drugs companies in 2021 (%)

The global Antiviral Drugs market was valued at 42060 million in 2021 and is projected to reach US$ 52240 million by 2028, at a CAGR of 3.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Reverse Transcriptase Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antiviral Drugs include Roche, Johnson & Johnson, Merck, Novartis, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and AbbVie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antiviral Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antiviral Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antiviral Drugs Market Segment Percentages, by Type, 2021 (%)

• Reverse Transcriptase Inhibitors
• Protease Inhibitors
• Fusion Inhibitors
• Immune System Modulators

Global Antiviral Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antiviral Drugs Market Segment Percentages, by Application, 2021 (%)

• Hepatitis Therapeutics
• HIV/AIDS Therapeutics
• Herpes Therapeutics
• Influenza Therapeutics

Global Antiviral Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antiviral Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antiviral Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Antiviral Drugs revenues share in global market, 2021 (%)

Key companies Antiviral Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Antiviral Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Johnson & Johnson
• Merck
• Novartis
• Bristol-Myers Squibb
• Gilead Sciences
• GlaxoSmithKline
• AbbVie

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antiviral Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antiviral Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIVIRAL DRUGS OVERALL MARKET SIZE

2.1 Global Antiviral Drugs Market Size: 2021 VS 2028
2.2 Global Antiviral Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antiviral Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Antiviral Drugs Players in Global Market
3.2 Top Global Antiviral Drugs Companies Ranked by Revenue
3.3 Global Antiviral Drugs Revenue by Companies
3.4 Global Antiviral Drugs Sales by Companies
3.5 Global Antiviral Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antiviral Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antiviral Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antiviral Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Antiviral Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Antiviral Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antiviral Drugs Market Size Markets, 2021 & 2028
  4.1.2 Reverse Transcriptase Inhibitors
  4.1.3 Protease Inhibitors
  4.1.4 Fusion Inhibitors
  4.1.5 Immune System Modulators
4.2 By Type - Global Antiviral Drugs Revenue & Forecasts
  4.2.1 By Type - Global Antiviral Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Antiviral Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Antiviral Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Antiviral Drugs Sales & Forecasts
  4.3.1 By Type - Global Antiviral Drugs Sales, 2017-2022
  4.3.2 By Type - Global Antiviral Drugs Sales, 2023-2028
  4.3.3 By Type - Global Antiviral Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Antiviral Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antiviral Drugs Market Size, 2021 & 2028
  5.1.2 Hepatitis Therapeutics
  5.1.3 HIV/AIDS Therapeutics
  5.1.4 Herpes Therapeutics
  5.1.5 Influenza Therapeutics
5.2 By Application - Global Antiviral Drugs Revenue & Forecasts
  5.2.1 By Application - Global Antiviral Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Antiviral Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Antiviral Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Antiviral Drugs Sales & Forecasts
  5.3.1 By Application - Global Antiviral Drugs Sales, 2017-2022
  5.3.2 By Application - Global Antiviral Drugs Sales, 2023-2028
  5.3.3 By Application - Global Antiviral Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Antiviral Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antiviral Drugs Market Size, 2021 & 2028
6.2 By Region - Global Antiviral Drugs Revenue & Forecasts
  6.2.1 By Region - Global Antiviral Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Antiviral Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Antiviral Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Antiviral Drugs Sales & Forecasts
  6.3.1 By Region - Global Antiviral Drugs Sales, 2017-2022
  6.3.2 By Region - Global Antiviral Drugs Sales, 2023-2028
  6.3.3 By Region - Global Antiviral Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Antiviral Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Antiviral Drugs Sales, 2017-2028
  6.4.3 US Antiviral Drugs Market Size, 2017-2028
  6.4.4 Canada Antiviral Drugs Market Size, 2017-2028
  6.4.5 Mexico Antiviral Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Antiviral Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Antiviral Drugs Sales, 2017-2028
  6.5.3 Germany Antiviral Drugs Market Size, 2017-2028
  6.5.4 France Antiviral Drugs Market Size, 2017-2028
  6.5.5 U.K. Antiviral Drugs Market Size, 2017-2028
  6.5.6 Italy Antiviral Drugs Market Size, 2017-2028
  6.5.7 Russia Antiviral Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Antiviral Drugs Market Size, 2017-2028
  6.5.9 Benelux Antiviral Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Antiviral Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Antiviral Drugs Sales, 2017-2028
  6.6.3 China Antiviral Drugs Market Size, 2017-2028
  6.6.4 Japan Antiviral Drugs Market Size, 2017-2028
  6.6.5 South Korea Antiviral Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Antiviral Drugs Market Size, 2017-2028
  6.6.7 India Antiviral Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Antiviral Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Antiviral Drugs Sales, 2017-2028
  6.7.3 Brazil Antiviral Drugs Market Size, 2017-2028
  6.7.4 Argentina Antiviral Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Antiviral Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Antiviral Drugs Sales, 2017-2028
  6.8.3 Turkey Antiviral Drugs Market Size, 2017-2028
  6.8.4 Israel Antiviral Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Antiviral Drugs Market Size, 2017-2028
  6.8.6 UAE Antiviral Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Antiviral Drugs Major Product Offerings
  7.1.4 Roche Antiviral Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Roche Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Antiviral Drugs Major Product Offerings
  7.2.4 Johnson & Johnson Antiviral Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Antiviral Drugs Major Product Offerings
  7.3.4 Merck Antiviral Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Merck Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Antiviral Drugs Major Product Offerings
  7.4.4 Novartis Antiviral Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Novartis Key News
7.5 Bristol-Myers Squibb
  7.5.1 Bristol-Myers Squibb Corporate Summary
  7.5.2 Bristol-Myers Squibb Business Overview
  7.5.3 Bristol-Myers Squibb Antiviral Drugs Major Product Offerings
  7.5.4 Bristol-Myers Squibb Antiviral Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Bristol-Myers Squibb Key News
7.6 Gilead Sciences
  7.6.1 Gilead Sciences Corporate Summary
  7.6.2 Gilead Sciences Business Overview
  7.6.3 Gilead Sciences Antiviral Drugs Major Product Offerings
  7.6.4 Gilead Sciences Antiviral Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 Gilead Sciences Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline Antiviral Drugs Major Product Offerings
  7.7.4 GlaxoSmithKline Antiviral Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 GlaxoSmithKline Key News
7.8 AbbVie
  7.8.1 AbbVie Corporate Summary
  7.8.2 AbbVie Business Overview
  7.8.3 AbbVie Antiviral Drugs Major Product Offerings
  7.8.4 AbbVie Antiviral Drugs Sales and Revenue in Global (2017-2022)
  7.8.5 AbbVie Key News

8 GLOBAL ANTIVIRAL DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Antiviral Drugs Production Capacity, 2017-2028
8.2 Antiviral Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Antiviral Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTIVIRAL DRUGS SUPPLY CHAIN ANALYSIS

10.1 Antiviral Drugs Industry Value Chain
10.2 Antiviral Drugs Upstream Market
10.3 Antiviral Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Antiviral Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Antiviral Drugs in Global Market
Table 2. Top Antiviral Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antiviral Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antiviral Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Antiviral Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Antiviral Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antiviral Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Antiviral Drugs Product Type
Table 9. List of Global Tier 1 Antiviral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiviral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antiviral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antiviral Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antiviral Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antiviral Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Antiviral Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Antiviral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antiviral Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antiviral Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antiviral Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Antiviral Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Antiviral Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antiviral Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antiviral Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antiviral Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Antiviral Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antiviral Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Antiviral Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antiviral Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Antiviral Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antiviral Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Antiviral Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antiviral Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Antiviral Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antiviral Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Antiviral Drugs Sales, (K Units), 2023-2028
Table 46. Roche Corporate Summary
Table 47. Roche Antiviral Drugs Product Offerings
Table 48. Roche Antiviral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Antiviral Drugs Product Offerings
Table 51. Johnson & Johnson Antiviral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Antiviral Drugs Product Offerings
Table 54. Merck Antiviral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Novartis Corporate Summary
Table 56. Novartis Antiviral Drugs Product Offerings
Table 57. Novartis Antiviral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Bristol-Myers Squibb Corporate Summary
Table 59. Bristol-Myers Squibb Antiviral Drugs Product Offerings
Table 60. Bristol-Myers Squibb Antiviral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Gilead Sciences Corporate Summary
Table 62. Gilead Sciences Antiviral Drugs Product Offerings
Table 63. Gilead Sciences Antiviral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. GlaxoSmithKline Corporate Summary
Table 65. GlaxoSmithKline Antiviral Drugs Product Offerings
Table 66. GlaxoSmithKline Antiviral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. AbbVie Corporate Summary
Table 68. AbbVie Antiviral Drugs Product Offerings
Table 69. AbbVie Antiviral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Antiviral Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global Antiviral Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Antiviral Drugs Production by Region, 2017-2022 (K Units)
Table 73. Global Antiviral Drugs Production by Region, 2023-2028 (K Units)
Table 74. Antiviral Drugs Market Opportunities & Trends in Global Market
Table 75. Antiviral Drugs Market Drivers in Global Market
Table 76. Antiviral Drugs Market Restraints in Global Market
Table 77. Antiviral Drugs Raw Materials
Table 78. Antiviral Drugs Raw Materials Suppliers in Global Market
Table 79. Typical Antiviral Drugs Downstream
Table 80. Antiviral Drugs Downstream Clients in Global Market
Table 81. Antiviral Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Antiviral Drugs Segment by Type
Figure 2. Antiviral Drugs Segment by Application
Figure 3. Global Antiviral Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antiviral Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antiviral Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Antiviral Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antiviral Drugs Revenue in 2021
Figure 9. By Type - Global Antiviral Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Antiviral Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antiviral Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Antiviral Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Antiviral Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antiviral Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Antiviral Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Antiviral Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antiviral Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antiviral Drugs Sales Market Share, 2017-2028
Figure 19. US Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antiviral Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antiviral Drugs Sales Market Share, 2017-2028
Figure 24. Germany Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antiviral Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antiviral Drugs Sales Market Share, 2017-2028
Figure 33. China Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antiviral Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antiviral Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antiviral Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antiviral Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antiviral Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Antiviral Drugs by Region, 2021 VS 2028
Figure 50. Antiviral Drugs Industry Value Chain
Figure 51. Marketing Channels